Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis

Infection and Immunity

Volumn 69, Issue 2, 2001, Pages 779-786

  Hazen, K C ^a   Wu, J G ^a   Masuoka, J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; MANNOPROTEIN;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CELL SURFACE; FUNGUS GROWTH; FUSOBACTERIUM NUCLEATUM; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; VIRULENCE;

BLOTTING, WESTERN; CANDIDA; CANDIDA ALBICANS; CELL WALL; EPITOPES; FUNGAL PROTEINS; IMMUNE SERA; MANNANS; OLIGOSACCHARIDES;

EID: 0035139892     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.2.779-786.2001     Document Type: Article

References (62)

1. Role of yeast cell growth temperature on Candida albicans virulence in mice
2. Candida dubliniensis fungemia: The first four cases in North America
3. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients
4. Microdetermination of phosphorus
5. Oral Candida in HIV infection and AIDS: New perspectives/new approaches
6. Candidiasis: The emergence of a novel species, Candida dubliniensis
7. Putative virulence factors of Candida albicans
8. Fungal factors implicated in pathogenesis
9. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells
10. Colorimetric method for determination of sugars and related substances
11. β-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage
12. Candida dubliniensis: Phylogeny and putative virulence factors
13. Expression of surface hydrophobic proteins by Candida albicans in vivo
14. Relative abundance of oligosaccharides in Candida species as determined by fluorophore-assisted carbohydrate electrophoresis
15. Antibody response that protects against disseminated candidiasis
16. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies
17. Candida mannan can induce protective antibodies in mice
18. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection
19. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody
20. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis
21. Comparative pathogenicity of Candida albicans for mice and rabbits
22. Dynamic expression of cell surface hydrophobicity during initial yeast cell growth and before germ tube formation of Candida albicans
23. Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells
24. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues
25. Cell surface hydrophobicity and medically important fungi
26. Hydrophobic cell wall protein glycosylation by the pathogenic fungus Candida albicans
27. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans
28. A polystyrene microsphere assay for detecting surface hydrophobicity variations within Candida albicans populations
29. Surface hydrophobic and hydrophilic protein alterations in Candida albicans
30. Temperature-modulated physiological characteristics of Candida albicans
31. Partial biochemical characterization of cell surface hydrophobicity and hydrophilicity of Candida albicans
32. Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata
33. Identification of Candida dubliniensis in a prospective study of patients in the United States
34. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum
35. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals
36. Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation
37. The use of polyacrylamide-gel electrophoresis for the high-resolution separation of reducing saccharides labelled with the fluorophore 8-aminonaphthalene-1,3,6-trisulphonic acid
38. Polyacrylamide gel electrophoresis of reducing saccharides labeled with the fluorophore 8-aminonaphthalene-1,3,6-trisulphonic acid: Application to the enzymological structural analysis of oligosaccharides
39. β-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production
40. Isolation, characterization, and partial structure of peptido galactomannans from the yeast form of Cladosporium werneckii
41. Cell wall mannosylation determines Candida albicans cell surface hydrophobicity
42. Differences in the acid-labile component of Candida albicans mannan from hydrophobic and hydrophilic yeast cells
43. Inhibition of Candida albicans attachment to extracellular matrix by antibodies which recognize hydrophobic cell wall proteins
44. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus
45. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation
46. Candida albicans serotype analysis by flow cytometry
47. Prevalence of Candida dubliniensis isolates in a yeast stock collection
48. Immunochemical study on bakers' yeast mannan prepared by fractional precipitation with cetylmethylammonium bromide
49. Polysaccharides of baker's yeast. Part IV. Mannan
50. Immunoreactivity of Candida albicans β-1, 2 linked oligomannosides and phospholipomannan
51. Clearances of Candida albicans-derived α- and β-linked mannose residues in sera from patients with candidiasis
52. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients
53. Measurement of protein using bicinchoninic acid
54. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients
55. Candida dubliniensis: An emerging opportunistic pathogen
56. Candida dubliniensis: Characteristics and identification
57. Candida dubliniensis: An update
58. Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals
59. Detection of β-1,2-mannosyltransferase in Candida albicans cells
60. Rapid differentiation of closely related Candida species and strains by pyrolysis-mass spectrometry and Fourier transform-infrared spectroscopy
61. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
62. Isolation and characterization of cell surface mutants of Candida albicans